Stay updated on Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial

Sign up to get notified when there's something new on the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the usual study record content; the top navigation and links to study documents appear unavailable, indicating the record is currently inaccessible.
    Difference
    22%
    Check dated 2026-09-21T22:13:30.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A new publication entry by McKenna M. et al. was added to the Publications list for Growth Outcomes After 48 Weeks of Dolutegravir in Children and Adolescents with HIV-1 in IMPAACT P1093 and IMPAACT 2019 (piag088, doi:10.1093/jpids/piag088). This adds a recent outcomes study to the page's referenced literature, helping readers find related results from the DTG pediatric program.
    Difference
    0.0%
    Check dated 2026-09-14T18:22:29.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, indicating a minor update to the page’s rendering or metadata. This change does not alter study data or content, but reflects an incremental improvement to the site itself.
    Difference
    0.0%
    Check dated 2026-08-31T16:21:54.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, indicating a new revision of the study details page. This appears to be a minor metadata update rather than a substantive change to content or features.
    Difference
    0.0%
    Check dated 2026-08-10T06:59:38.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.6.3 to v3.6.4, indicating a newer release of the page content.
    Difference
    0.0%
    Check dated 2026-07-26T19:00:36.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Revision label in the Study Documents section was updated from v3.6.2 to v3.6.3, indicating a new document revision.
    Difference
    0.0%
    Check dated 2026-07-05T11:33:38.000Z thumbnail image

Stay in the know with updates to Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page.